Extracting Potential New Targets for Treatment of Adenoid Cystic Carcinoma using Bioinformatic Methods

Area of Science:

• Oncology
• Bioinformatics
• Genomics

Background:

• Adenoid cystic carcinoma (ACC) is a slow-growing malignancy primarily affecting salivary glands.
• Currently, there are no FDA-approved therapeutic targets or diagnostic biomarkers for ACC.
• This study aimed to identify novel therapeutic and diagnostic targets for ACC using bioinformatics approaches.

Purpose of the Study:

• To identify potential diagnostic and therapeutic targets for adenoid cystic carcinoma (ACC).
• To explore key biochemical pathways involved in ACC pathogenesis.
• To validate potential biomarkers for ACC.

Main Methods:

• Gene expression data from two GEO datasets (GSE59701, GSE88804) were analyzed.
• Differentially expressed genes were identified using R software.
• Pathway enrichment analysis was performed using Enrichr, and protein-protein interaction (PPI) networks were constructed with STRING and visualized with Cytoscape. Biomarker verification used real-time PCR and immunohistochemistry.

Main Results:

• Twenty hub genes with potential as diagnostic and therapeutic targets were identified from the PPI network analysis.
• PLCG1 was highlighted as a novel potential biomarker for ACC.
• The insulin-like growth factor type 1 receptor and PPARG pathways were identified as critically involved in ACC tumorigenesis and drug resistance, suggesting their therapeutic potential.

Conclusions:

• This study successfully identified key pathways and potential targets for ACC diagnosis and treatment.
• Further experimental validation is necessary to confirm the identified targets and pathways for clinical application.